EPR oxygen images predict tumor control by a 50% tumor control radiation dose

Cancer Research

Volumn 73, Issue 17, 2013, Pages 5328-5335

  Elas, Martyna ^a,b,c   Magwood, Jessica M ^a,b   Butler, Brandi ^a,b   Li, Chanel ^a,b   Wardak, Rona ^a,b   Barth, Eugene D ^a,b   Epel, Boris ^a,b   Rubinstein, Samuel ^a,b   Pelizzari, Charles A ^a   Weichselbaum, Ralph R ^a   Halpern, Howard J ^a,b  

^a UNIVERSITY OF CHICAGO   (United States)

^b University of Chicago   (United States)

^c JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CONTROL; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CONTROLLED STUDY; ELECTRON SPIN RESONANCE; ELECTRON SPIN RESONANCE OXYGEN IMAGING; FEMALE; FIBROSARCOMA; HYPOXIA; IMAGING; MOUSE; NONHUMAN; OXIMETRY; PREDICTION; PRIORITY JOURNAL; RADIATION DOSE; TREATMENT FAILURE;

ADENOCARCINOMA; ANIMALS; ANOXIA; ELECTRON SPIN RESONANCE SPECTROSCOPY; FEMALE; FIBROSARCOMA; IMAGE PROCESSING, COMPUTER-ASSISTED; MICE; MICE, INBRED C3H; OXYGEN; PROGNOSIS; RADIATION TOLERANCE; RADIOTHERAPY DOSAGE; SURVIVAL RATE; TUMOR CELLS, CULTURED;

EID: 84883467646     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-13-0069     Document Type: Article

References (42)

1. Schwarz G. Uber Desensibilisierung gegen Rontgen- und Radiumstrahlen. MMW Munch Med Wochenschr 1909;56:1217-8.
2. Henk JM, Kunkler PB, Smith CW. Radiotherapy and hyperbaric oxygen in head and neck cancer. Final report of first controlled clinical trial. Lancet 1977;2:101-3. (Pubitemid 8124942)
3. Henk JM, Smith CW. Radiotherapy and hyperbaric oxygen in head and neck cancer. Interim report of second clinical trial. Lancet 1977;2:104-5. (Pubitemid 8124943)
4. Wardman P. Chemical radiosensitizers for use in radiotherapy. Clin Oncol 2007;19:397-417. (Pubitemid 46995615)
5. Overgaard J. Hypoxic radiosensitization: adored and ignored. J Clin Oncol 2007;25:4066-74. (Pubitemid 47492951)
6. Overgaard J. Hypoxic modification of radiotherapy in squamous cell carcinoma of the head and neck - a systematic review and meta-analysis. Radiother Oncol 2011;100:22-32.
7. Hockel M, Schlenger K, Aral B, Mitze M, Schaffer U, Vaupel P. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res 1996;56:4509-15. (Pubitemid 26330463)
8. 2 of orthotopic 9L and C6 gliomas and tumor-specific response to radiotherapy and hyperoxygenation. Int J Rad Oncol Biol Phys 2009;73:1-8.
9. Bratasz A, Pandian RP, Deng Y, Petryakov S, Grecula JC, Gupta N, et al. In vivo imaging of changes in tumor oxygenation during growth and after treatment. Magn Reson Med 2007;57:950-9. (Pubitemid 46709415)
10. Jordan BF, Gallez B. Surrogate MR markers of response to chemo- or radiotherapy in association with co-treatments: a retrospective analysis of multi-modal studies. Contrast Media Mol Imaging 2010;5:323-32.
11. Matsumoto K, Szajek L, Krishna MC, Cook JA, Seidel J, Grimes K, et al. The influence of tumor oxygenation on hypoxia imaging in murine squamous cell carcinoma using [64Cu] Cu-ATSM or [18F] fluoromisonidazole positron emission tomography. Int J Oncol 2007;30:873-81.
12. Halpern HJH, Yu C, Peric M, Barth ED, Grdina DJ, Teicher BA. Oxymetry deep in tissues with low-frequency electron paramagnetic resonance. Proc Natl Acad Sci U S A 1994;91:13047-51.
13. Velan SS, Spencer RG, Zweier JL, Kuppusamy P. Electron paramagnetic resonance oxygen mapping (EPROM): direct visualization of oxygen concentration in tissue. Magn Reson Med 2000;43:804-9. (Pubitemid 30387600)
14. Elas M, Williams BB, Parasca A, Mailer C, Pelizzari CA, Lewis MA, et al. Quantitative tumor oxymetric images from 4D electron paramagnetic resonance imaging (EPRI): methodology and comparison with blood oxygen level-dependent (BOLD) MRI. Magn Reson Med 2003;49:682-91. (Pubitemid 36389978)
15. Elas M, Ahn KH, Parasca A, Barth ED, Lee D, Haney C, et al. Electron paramagnetic resonance oxygen images correlate spatially and quantitatively with Oxylite oxygen measurements. Clin Cancer Res 2006;12:4209-17.
16. Elas M, Bell R, Hleihel D, Barth ED, McFaul C, Haney CR, et al. Electron paramagnetic resonance oxygen image hypoxic fraction plus radiation dose strongly correlates with tumor cure in FSa fibrosarcomas. Int J Radiat Oncol Biol Phys 2008;71:542-9. (Pubitemid 351636205)
17. Stone HB, Milas L. Modification of radiation responses of murine tumors by misonidazole (Ro 07-0582), host immune capability, and Corynebacterium parvum . J Natl Can Inst 1978;60:887-93. (Pubitemid 8331130)
18. Stone HB, Withers HR. Enhancement of radiation response of a murine mammary carcinoma by two nitrofuran derivatives. Rad Res 1975;64:443-51.
19. Epel B, Sundramoorthy S, Mailer C, Halpern H. A versatile high speed 250-MHz pulse imager for biomedical applications. Concepts Magn Reson Part B Magn Reson Eng 2008;33B:163-76.
20. Subramanian V, Epel B. A passive dual-circulator based transmit/receive switch for use with reflection resonators in pulse EPR. Concepts Magn Reson Part B Magn Reson Eng 2009;1:1-13.
21. Ahn K-H, Halpern HJ. Spatially uniform sampling in 4-D EPR spectral-spatial imaging. J Magn Reson 2007;185:152-8. (Pubitemid 46505278)
22. Williams BB, Hallaq H, Chandramouli GVR, Barth ED, Rivers JN, Lewis M, et al. Imaging spin probe distribution in the tumor of a living mouse with 250 MHz EPR: correlation with BOLD MRI. Magn Reson Med 2002;47:634-8. (Pubitemid 34263775)
23. Epel B, Halpern HJ. Electron paramagnetic resonance oxygen imaging in vivo. In:Gilbert B, Chechik V, Murphy D, editors. Electron paramagnetic resonance. Cambridge, UK: RSC Publishing; 2013.
24. Suit H, Hwang T, Hsieh C, Howard D, Thames J. Design of radiation dose-response assays for tumor control. In:Kallman R, editor. Rodent tumor models in experimental cancer therapy. New York, NY: Pergamon Press; 1987. p. 154-64.
25. Höckel M, Schlenger K, Mitze M, Schäffer U, Vaupel P. Hypoxia and radiation response in human tumors. Semin Rad Oncol 1996;6:3-9. (Pubitemid 26029370)
26. Williams B, Ahn K-H, Mailer C, Halpern H. Extraction of linewidth information from spatial-spectral EPR images using spectral fitting. In:Eaton G, Eaton S, editors. 44th Rocky Mountain Conference on Analytical Chemistry, EPR Symposium; 2002.
27. Ling CC, Humm J, Larson S, Amols H, Fuks Z, Leibel S, et al. Towards multidimensional radiotherapy (MD-CRT): biological imaging and biological conformality. Int J Rad Oncol Biol Phys 2000;47:551-60. (Pubitemid 30317470)
28. Thorwarth D, Alber M. Implementation of hypoxia imaging into treatment planning and delivery. Radiother Oncol 2010;97:172-5.
29. Thorwarth D, Eschmann S-M, Paulsen F, Alber M. Hypoxia dose painting by numbers: a planning study. Int J Rad Oncol Biol Phys 2007;68:291-300. (Pubitemid 46589864)
30. Vaupel P, Höckel M, Mayer A. Detection and characterization of tumor hypoxia using pO2 histography. Antioxid Redox Signal 2007;9:1221-35. (Pubitemid 47080831)
31. Gatenby RA, Kessler HB, Rosenblum JS, Coia LR, Moldofsky PJ, Hartz WH, et al. Oxygen distribution in squamous cell carcinoma metastases and its relationship to outcome of radiation therapy. Int J Rad Oncol Biol Phys 1988;14:831-8.
32. 2 tension. Am J Physiol 1996;271:C1172-80.
33. Höckel M, Vaupel P. Biological consequences of tumor hypoxia. Semin Oncol 2001;28:36-41. (Pubitemid 32522236)
34. 2 and its effect on radiotherapeutic efficacy of orthotopic F98 gliomas. Int J Rad Oncol Biol Phys 2010;78:1193-200.
35. 2 as a potential marker of therapeutic response. Radiat Res 2009;172:592-7.
36. Diepart C, Karroum O, Magat J, Feron O, Verrax J, Calderon PB, et al. Arsenic trioxide treatment decreases the oxygen consumption rate of tumor cells and radiosensitizes solid tumors. Cancer Res 2012;72:482-90.
37. Jordan BF, Peeterbroeck J, Karroum O, Diepart C, Magat J, Grégoire V, et al. Captopril and S-nitrosocaptopril as potent radiosensitizers: comparative study and underlying mechanisms. Cancer Lett 2010;293:213-9.
38. Ansiaux R, Dewever J, Grégoire V, Feron O, Jordan BF, Gallez B.Decrease in tumor cell oxygen consumption after treatment with vandetanib (ZACTIMA; ZD6474) and its effect on response to radiotherapy. Radiat Res 2009;172:584-91.
39. 2. Radiat Res 2012;177:376-86.
40. Hall E. Radiobiology for the radiologist. 5th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2000.
41. Kallman R. Rodent tumor models in experimental cancer therapy. New York, NY: Pergamon Press; 1987.
42. 2 in a murine tumor after irradiation: an in vivo electron paramagnetic resonance oximetry study. Radiat Res 1995;144:222-9.